Quang X. Pham, Chairman, CEO and Interim CFO, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 11,444 shares at $3.55 ($40K) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($40k) by Chairman, CEO and Interim CFO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.55 | 9,167 | $33K | 81.7% |
| 2 | $3.20 | 2,277 | $7K | 18.3% |
| Total | $3.48 avg | 11,444 | $40K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |
| CVKD | SELL | 2026-06-10 | $93K | — | Filing → |